Therefore, the prior identification of HLA-DRB1 alleles may be useful not only for selecting an appropriate molecular targeted therapy, but also for predicting disease progression in patients with RA in daily clinical practice. This evidence concerns the gene HLA-DRB1 and rheumatoid arthritis.